Posted in: Games, Video Games | Tagged: , ,

Experiment 101 Acquired By THQ Nordic Along With 'Biomutant'

Published
by
|
Last updated
|
Comments

THQ Nordic has acquired a brand new studio in Experiment 101, the people behind Biomutant which is currently still in development. The news came down on their blog over the weekend, officially putting the IP in their hands as the game is still on track for a 2018 release. No word as tot he status of the employees of Experiment 101 of what THQ Nordic plans to do with the rest of the company's assets, but it does give a glimmer of hope that we'll see Biomutant sooner than expected!

Experiment 101 Acquired By THQ Nordic Along With 'Biomutant'

THQ Nordic is announcing today that it has acquired 100% of the shares from Experiment 101 AB, as well as the intellectual property of Biomutant® the open-word, post-apocalyptic Kung-Fu fable RPG, which is now part of the THQ Nordic portfolio. The IP-acquisition itself is being handled by THQ Nordic AB, based in Karlstad, Sweden, whereas the day-to-day business will be handled by THQ Nordic GmbH, based in Vienna, Austria. Experiment 101 is currently working on Biomutant® for PC, PlayStation 4 and Xbox One. More details on one of the biggest surprise hits of this year's Gamescom will be revealed in 2018.

Enjoyed this? Please share on social media!

Stay up-to-date and support the site by following Bleeding Cool on Google News today!

Gavin SheehanAbout Gavin Sheehan

Gavin is the current Games Editor for Bleeding Cool. He has been a lifelong geek who can chat with you about comics, television, video games, and even pro wrestling. He can also teach you how to play Star Trek chess, be your Mercy on Overwatch, recommend random cool music, and goes rogue in D&D. He also enjoys hundreds of other geeky things that can't be covered in a single paragraph. Follow @TheGavinSheehan on Facebook, Twitter, Instagram, and Vero, for random pictures and musings.
twitterfacebookinstagram
Comments will load 20 seconds after page. Click here to load them now.